Clinical Trials Logo

Wounds and Injuries clinical trials

View clinical trials related to Wounds and Injuries.

Filter by:

NCT ID: NCT06452264 Not yet recruiting - Clinical trials for Spinal Cord Injuries

Early Intervention for Information Processing Speed Deficits in Acute SCI: A Pilot Study

SCI-IQ
Start date: June 5, 2024
Phase: N/A
Study type: Interventional

This study seeks conduct a pilot study to test whether a cognitive training program can improve processing speed abilities in individuals with acute traumatic spinal cord injury.

NCT ID: NCT06451133 Not yet recruiting - Clinical trials for Spinal Cord Injuries

Hemodynamic Management Following Acute Traumatic Spinal Cord Injury

Start date: June 15, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effect of various hemodynamic management strategies on functional neurologic outcomes and non-neurologic adverse events in the first 5 days following acute spinal cord injury (SCI). The hemodynamic management strategies assessed include targeting a mean arterial blood pressure (MAP) goal of 85-90 mmHg, targeting a spinal cord perfusion pressure (SCPP) goal of ≥65 mmHg, or targeting normal hemodynamics, which is a MAP goal of ≥65 mmHg.

NCT ID: NCT06449183 Recruiting - Clinical trials for Mild Traumatic Brain Injury

VIDAS® TBI Performance in Subjects With Mild Traumatic Brain Injury (mTBI)

Start date: May 16, 2024
Phase: N/A
Study type: Interventional

Decision Rules for an initial CT-scan in patients arriving to Emergency Department (ED) and presenting a mild traumatic brain injury could be optimized by the use of an objective parameter easily and rapidly measured. This may be the place for serum biomarkers providing a quick and accurate assessment. BioMérieux has now developed an automated assay for the measurement of serum Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin C-terminal Hydrolase (UCH-L1), the VIDAS® TBI assay to fill out this unmet needs. The goal of the herein study is to generate real-world data and evidences to support the VIDAS® TBI performances.

NCT ID: NCT06446609 Recruiting - Pruritus Clinical Trials

Drug-induced Liver Injury: Itching Study

Start date: June 14, 2024
Phase:
Study type: Observational

Idiosyncratic drug-induced liver injury (DILI) is an unpredictable adverse hepatic reaction to a medication used in its therapeutic dose. DILI is the second most common cause of itching in adult Hepatology after biliary obstruction. In particular cholestatic or mixed pattern types of DILI (in which bile flow from the liver is impaired) are associated with long-lasting effects as well as reduced quality of life. There is therefore an urgent need to determine the incidence and natural history of itching in DILI and establish a network of centres that will form a basis for a clinical trial to investigate a novel intervention to treat these.

NCT ID: NCT06444672 Completed - Clinical trials for Spinal Cord Injury L1- L5

Effects of a Home-Based Rehabilitation on Anthropometric Measures, Sensory-Motor Functions and Independence After Spinal Cord Injury

HBRSCI
Start date: September 25, 2021
Phase: N/A
Study type: Interventional

Background: The scarcity of resources for spinal cord injury (SCI) rehabilitation constitutes a significant obstacle, particularly in war-torn regions experiencing a rise in such injuries. Implementing a home-based rehabilitative program (HBRP) tailored to patients' environmental, social, and financial contexts is crucial in mitigating this challenge. The authors investigated the effects of a 24-month HBRP on anthropometric measurements, muscular strength, sensory and motor function, and independence in participants transitioning from bed to walking following SCI. Methods: Serial case study in a quasi-experimental design, the conducting was at the participants' homes. The participants were four patients with SCI (experimental group) and another two patients with SCI (control group). The interventions were a 24-month HBRP comprising strength, flexibility, and balance training, the outcome measures involved anthropometric measurements, muscle strength using a digital handheld dynamometer, muscle thickness, and cross-sectional area measured using magnetic resonance imaging, measured five walking tests, and the American Spinal Injury Association scale (ASIA) score for assess the sensory and motor score, and the Spinal Cord Independence Measure (SCIM).

NCT ID: NCT06443281 Recruiting - Clinical trials for Spinal Cord Injuries

Pain Phenotyping in Patients With Neuropathic Pain After Spinal Cord Injury

Start date: April 17, 2024
Phase:
Study type: Observational

The development of neuropathic pain is one of the most debilitating sequels after a spinal cord injury (SCI). The overall aim of this study is to investigate potential underlying pathophysiological mechanisms of neuropathic pain after SCI. The functionality of the nociceptive pathway in humans as well as its plastic changes following SCI will be inferred with sophisticated sensory and pain phenotyping using quantitative sensory testing (i.e., psychophysical measures), objective neurophysiological measures of pain processing and the recording of pain-related autonomic responses (i.e., galvanic skin response, cardiovascular measures and pupil dilation). In addition, the interplay between the somatosensory and autonomic nervous system and its association with the development and maintenance of neuropathic pain after SCI will be investigated.

NCT ID: NCT06442956 Not yet recruiting - Heat Stress Clinical Trials

Effect of Rapid Heat Stress on Firefighters Musculoskeletal Injury Risk

Start date: July 2024
Phase: N/A
Study type: Interventional

This study will examine the effect of heat stress on factors that influence musculoskeletal injury risk in firefighters. Participants will attend 4 data collection sessions. 1: informed consent, screening, and familiarization. 2: pre-tests (strength, balance, and movement quality). 3: heat stress (rapid or gradual) followed by post-tests (strength, balance, and movement quality). 4: heat stress (rapid or gradual) followed by post-tests.

NCT ID: NCT06442332 Completed - Injuries Clinical Trials

Long-term Consequences of Cyclist Injuries

RECYCLIST WP4
Start date: June 26, 2023
Phase:
Study type: Observational

There is a lack of knowledge about the extent of bicycle injuries in Norway. Among other things, a significant underreporting of bicycle injuries has been found in the official road traffic accident statistics based on police-registered accidents. Furthermore, there is a lack of knowledge about the long-term consequences of serious bicycle injuries. The main purpose of this project is to generate new knowledge about the consequences of bicycle injuries for later disability, employment status and use of prescribed drugs. In addition, the investigators want to study whether such long-term consequences vary according to demographic and socioeconomic characteristics, as well as to assess the degree of overlap between bicycle injuries registered in the official road traffic accident statistics and bicycle injuries registered in the health service, including an assessment of the severity of the injury. The investigators will use a retrospective analysis where a population-based dataset from the National Population Register is linked with information on injured cyclists from Statistics Norway's database on police-reported road traffic accidents, the Norwegian Patient Register, the National Trauma Registry and the Norwegian Cause of Death Registry. In order to study the long-term consequences of bicycle injuries, the investigators will also compile information on social security benefits and employment from Statistics Norway's historical events database (FD-Trygd) and the use of prescribed drugs from the Norwegian Prescribed Drug Registry. The investigators will also collect information on income and educational attainment from registers in Statistics Norway. The project will contribute to increased knowledge about the societal and individual burden of bicycle injuries, knowledge that is crucial for prioritizing and implementing necessary preventive measures.

NCT ID: NCT06442319 Recruiting - Knee Osteoarthritis Clinical Trials

The Efficiency and Safety of PRP Treatment After Anterior Cruciate Ligament Reconstruction.

Start date: June 1, 2024
Phase: N/A
Study type: Interventional

The anterior cruciate ligament (ACL) is the main stabilizer of the knee joint, as it controls anteroposterior and rotatory knee laxity. The number of ACL injuries has increased in the past three decades because more and more people participate in recreational and competitive sporting activities. Injury to the ACL often leads to functional instability, damage to the meniscus and articular cartilage, and an increased risk for osteoarthritis (OA). Emphasizes the fact that ACL has limited healing potential 'The gold standard' treatment is ACL reconstruction, with over 200,000 reconstruction surgeries performed annually in the United States. However, despite the success of surgery in restoring functional stability, it has been found so far in several studies that the prevalence of moderate to severe arthritis in long-term radiographic follow-up is more than 50% after ACL reconstruction within 5 to 15 years or sooner. ACL-injured knees had at least 3 times higher risk of arthritis than uninjured contralateral knees. Early osteoarthritis was observed on magnetic resonance imaging (MRI) up to 11 years following ACL injury after operative and nonoperative management. Because ACL injuries predominantly occur in individuals between the ages of 15 and 25 years, symptoms of OA most often affect patients during their most productive years. This is worrisome because most patients who sustain ACL tears are free of the risk of other factors for developing OA.Consequently, posttraumatic OA after ACL reconstruction ultimately translates into a large economic effect on the healthcare system owing to the young age of this population. Platelet-rich plasma is an autologous solution of highly concentrated platelets dispersed in a small capacity of plasma. Enthusiasm for the therapeutic potential of platelets is based on its rich omplement of anabolic growth factors and anti-inflammatory cytokines in the platelets, which induce cellular proliferation, migration, differentiation, angiogenesis, and extracellular matrix synthesis. In addition, the functional mechanisms of PRP in OA treatment have been explained by its effect on modulating critical pro-inflammatory mediators and catabolic enzymes, as well as maintaining joint homeostasis. The reasons for this early incidence of post-traumatic OA remain unclear, but the underlying mechanisms have been speculated to involve some combination of cartilage damage at the time of injury, and posttraumatic molecular changes in the joint, including immune reactions or persistent secondary inflammation. We hypothesized that PRP injection after ACL reconstruction could prevent cartilage damage, act anti-inflammatory, and provide better clinical and radiological outcomes seen in MRI.

NCT ID: NCT06439108 Active, not recruiting - Clinical trials for Evaluation of Single Symphyseal Plating in APC III Injuries

Single vs Double Symphyseal Plating in Management of Vertically Unstable Open Book Pelvic Ring Injuries:

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

compare functional, radiological outcomes, implant failure and the incidence of recurrent diastasis of single superior symphyseal plate versus double plating in management of vertically unstable open book injuries